Author

Shreena Kalaria

Observed name: Kalaria, Shreena Nisha

Institution: BC Cancer Agency

Observed institutions: BC Cancer Agency, University of Victoria

ORCID: 0009-0006-5586-3462

Observed ORCID: 0009-0006-5586-3462

OpenAlex ID: A5040124786

Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer

2023 · Nikki L. Burdett, Madelynne O. Willis, et al. · Nature Genetics · 85

Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer

2024 · Brad H. Nelson, Phineas Hamilton, et al. · Journal of Clinical Investigation · 19

N-MYC impairs innate immune signaling in high-grade serous ovarian carcinoma

2024 · Alex Miranda, Swetansu Pattnaik, et al. · Science Advances · 19

CD8 + T cell infiltration is associated with improved survival and negatively correlates with hypoxia in clear cell ovarian cancer

2023 · Nancy Guo, Aijun Yang, et al. · Scientific Reports · 19

Prognostically Favorable Immune Responses to Ovarian Cancer are Distinguished by Self-Reactive Intra-Epithelial Plasma Cells

2025 · Allyson C. Banville, Céline M. Laumont, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1

SPaCeD: Spatial Point Process Distances for Pairing the Heavy and Light Chains of B Cell Receptors from Spatial BCR-seq

2026 · Yimeng Liu, Céline M. Laumont, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Recurrent transcriptomic states of plasma cell rich lymphomyeloid aggregates in high grade serous ovarian carcinoma

2026 · Kalaria, Shreena Nisha · UVic’s Research and Learning Repository (University of Victoria)

Generalized Jeffreys's approximate objective Bayes factor: Model-selection consistency, finite-sample accuracy, and statistical evidence in 71,126 clinical trial findings

2025 · Velidi, Puneet, Wei, Zhengxiao, et al. · arXiv (Cornell University)

Works count: 8

Citation count: 143

H-index: 4

I10-index: 4